Wyszukaj badanie kliniczne
23 Wyniki
Badanie kliniczne z otwartą rekrutacją
= 
; Badanie kliniczne w toku
= 
; Ufundowane przez członka IRDiRC = 
; MISSING CONTENT = 
Krajowe badania kliniczne
AUSTRIA
WIEN
WIEN
VINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie
AUSTRIA
WIEN
WIEN
Phase I/II Open Label, Dose Escalation Trial to Determine the MTD, Safety, PK and Efficacy of Afatinib Monotherapy in Children Aged 1 Year to <18 Years With Recurrent/Refractory Neuroectodermal Tumours, Rhabdomyosarcoma and/or Other Solid Tumours With Known ErbB Pathway Deregulation Regardless of Tumour Histology - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde
FRANCJA
HAUTS-DE-FRANCE
LILLE
OVIMA : Etude de phase II évaluant l'efficacité de la Vinorelbine par voie orale chez des enfants porteurs d'un gliome de bas grade non extirpable ou en rechute
CLCC Oscar Lambret
Unité d'oncologie pédiatrique
FRANCJA
ILE-DE-FRANCE
VILLEJUIF
VINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent
POLSKA
Warszawa
WARSZAWA
Kooperacyjne Wieloośrodkowe Badanie Dzieci i Młodzieży z Glejakami o Niskim Stopniu Złośliwości
Instytut "Pomnik-Centrum Zdrowia Dziecka"
Klinika Onkologii IP-CZD
PORTUGALIA
NORTE
PORTO
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PT
Centro Hospitalar Universitário de S. João, EPE
Unidade de Hematologia e Oncologia Pediátrica
STANY ZJEDNOCZONE AMERYKI
California
LA JOLLA
A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas - US
University of California San Diego
University of California, San Diego
FRANCJA
AUVERGNE-RHONE-ALPES
GRENOBLE
Molecular and Cellular Print Medical Device Validation in Adult Glioma Tumors (Phase I) - FR
Centre Hospitalier Universitaire Grenoble Alpes
WŁOCHY
LAZIO
ROMA
Studio internazionale, di fase II, in aperto, per valutare l'effetto di dabrafenib in combinazione con trametinib in bambini e adolescenti con glioma a basso grado (LGG) o glioma ad alto grado (HGG) recidivante o refrattario positivo per mutazione di BRAF V600
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Oncoematologia
AUSTRIA
NIEDERÖSTERREICH
ST. PÖLTEN
LAHENE Study: Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy (phase 2)
Universitätsklinikum St. Pölten
Karl Landsteiner Institut für klinische Neurologie und Neuropsychologie
AUSTRIA
WIEN
WIEN
A Phase II, Open-label, Study in Subjects With BRAF V600E-Mutated Rare Cancers With Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie
FRANCJA
HAUTS-DE-FRANCE
LILLE
Cilengitide (EMD121974) en association à la radiothérapie chez l'enfant et les jeunes adultes porteur d'un gliome malin du tronc cérébral nouvellement diagnostiqué : Etude de phase I.
CLCC Oscar Lambret
Unité d'oncologie pédiatrique
FRANCJA
ILE-DE-FRANCE
PARIS
Etude évaluant le sulfate de Dexamfetamine chez des patients atteints d'un gliome et présentant une asthénie importante. Une étude de phase III en double aveugle versus un control placebo.
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie
FRANCJA
ILE-DE-FRANCE
VILLEJUIF
BIOMEDE: Thérapeutiques ciblées sur les biomarqueurs dans les gliomes diffus infiltrants du tronc cérébral (Phase II) - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent
NIEMCY
Berlin
ADDRESS: NOT PROVIDED - DE
PIVOT IO 020: Phase-1/2-Studie mit Bempegaldesleukin in Kombination mit Nivolumab bei Kindern, Jugendlichen und jungen Erwachsenen mit wiederkehrenden oder refraktären bösartigen Erkrankungen
Institution: Information not provided - DE
HISZPANIA
Madrid
ADDRESS: NOT PROVIDED - ES
Estudio de fase II abierto global para evaluar el efecto de dabrafenib en combinación con trametinib en pacientes niños y adolescentes con Glioma de Alto Grado (HGG) recidivante o refractario con mutación BRAF V600 positiva - ES
Institution: Information not provided - ES
HISZPANIA
Madrid
ADDRESS: NOT PROVIDED - ES
Estudio fase 1/2 de bempegaldesleukin en combinación con nivolumab en niños, adolescentes y adultos jóvenes con neoplasias malignas recidivantes o refractarias (PIVOT IO 020)
Institution: Information not provided - ES
SZWAJCARIA
Suisse Alémanique
BERN
LSCI-NSURG: Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery
Universitätsspital Inselspital
Universitätsklinik für Neurochirurgie
HOLANDIA
Noord-Holland
AMSTERDAM
The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Maag-Darm-Leveroncologie
BELGIA
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Programme d'extension à long terme du Sorafénib - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique
WŁOCHY
LAZIO
ROMA
Studio in aperto, a braccio singolo, di fase 1/2 che valuta la sicurezza e l'efficacia di Ponatinib per il trattamento delle leucemie ricorrenti o refrattarie o dei tumori solidi in pazienti pediatrici
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Oncoematologia
Wieloośrodkowe badania kliniczne
FRANCJA
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
VINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Institution: Information not provided - FR
ZJEDNOCZONE KRÓLESTWO
Leicestershire
LEICESTER